There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
KALA Weekly Chart

Old Forum Content for KALA

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
  • rjw225: @bigbartabs $KALA Thank you.
  • rjw225: $KALA a question to the more advanced members -- is it a tradeable squeeze? Thanks.
  • bigbartabs: @rjw225 $KALA ... I would say it is. If it hits 15.06, probably going higher. Next resistance point is probably around 15.43
  • rjw225: $KALA question to the more experienced members: Looks like a short squeeze, doesn't it?
  • scottrades: @rjw225 $KALA Certainly does! Not sure about the fundamental story but a monster move.
  • woodman: @scottrades $KALA - So many end of year monster moves in #biotech. Even though the bio ETFs aren't doing much, a number of individual bio stocks have crushed it. It's been the best part of my portfolio here at the end of the year.
  • scottrades: @woodman $KALA #biotech I agree. $XBI Still looks good on the Daily.
  • rjw225: $KALA is on the move. It is a tiny investigational eye treatment company. I am in it long term and still under water but others may benefit from short swings.
  • rjw225: $KALA is anybody in this stock? Is this an anti-short seller raid? Pray tell....
  • jr3345: $KALA - Mfg medicines for dry eye. Recent FDA approval & received upgrade with price target of $21. long stock
  • sierramp: @bRobert Do you know anything professionally about $KALA? They finished two phase III trials, got FDA approval in August for INVELTYS for temp relief of signs/symptoms of dry eye disease. They just did a secondary, looks like RA Capital Mgme got 4.5M shares. But the chart is pretty ugly.
  • bRobert: @sierramp $KALA No insight. Ugly stick sell off. Someone wasn't happy.
  • Aragorn: Recent IPOS making nice moves - $SNNA $KALA $AKSA - these are obviously risky -and thin do your own DD
  • Vehid: ATH #IPO $VERI (two-folded in two weeks w/o me :( ) $AKCA $PLNT $URGN $SNNS $KALA $TRTX
  • Bridget: @Vehid $VERI $AKCA $PLNT $URGN $SNNS $KALA $TRTX #IPO Also $SOI and $SGH
Visit the Trading Forum to join in the discussion.
Stock Price $6.00
Change -0.83%
Volume 16,341

Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.

Request Video of KALA
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!